Product Overview
CHOLERAVAC™ is an inactivated tetravalent water in oil (W/O) emulsified bacterial vaccine for immunization of chickens against Fowl Cholera.
You are viewing Sub-Saharan Africa
CHOLERAVAC™
CHOLERAVAC™ is an inactivated tetravalent water in oil (W/O) emulsified bacterial vaccine for immunization of chickens against Fowl Cholera.
Chickens.
Fowl cholera, also known as avian pasteurellosis, is a bacterial avian disease distributed globally, compromising health and productivitiy in all types of poultry production systems. Clinical signs are often characterized by acute fatal septicaemia, primarily in adult birds, while chronic and subclinical infections can also occur.1
In chronic forms of P. multocida infections, suppurative lesions may be widely found in the flock, often involving the respiratory tract, the conjunctiva and adjacent tissues of the head.2 Independent research indicates that infected birds can act as carriers of P. multocida without manifesting clinical signs, while surviving birds from infected flocks can also represent a risk factor.2
Inactivated vaccines are recognized as relevant tools in the control of this disease. Evidence suggests that inactivated fowl cholera vaccines confer reliable protection against the homologous challenge strains circulating in the field.1
Inactivated Pasteurella multocida antigens:
Active immunization of chickens to reduce mortality and clinical signs associated with Fowl Cholera.
Birds can be vaccinated from 2 weeks of age onwards and booster vaccination should take place within the next 6 weeks. The most suitable vaccination program shall be consulted with your poultry veterinarian according to the local epidemiological situation.
Zero days.
The vaccine dose (0.5 mL/bird) should be administered subcutaneously in the lower part of the neck.
Before use, the vaccine should be shaken well to ensure proper mixing. Sterile injection equipment should be used to avoid contamination.
The vaccine may occasionally separate into two layers on storage. This in no way affects its potency, but the vaccine should be shaken vigorously before and during use to ensure good emulsification. Do not use CHOLERAVAC™ if you notice critical irreversible separation of the emulsion.
CHOLERAVAC™ is packed and presented in 500 mL (1000 doses) polyethylene terephthalate (PET) bottles.
References
1. OIE Terrestrial Manual (2021). Chapter 3.3.9. – Fowl cholera. https://www.woah.org/fileadmin/Home/fr/Health_standards/tahm/3.03.09_FOWL_CHOLERA.pdf.
2. Jens Peter Christensen, J.P. and Magne Bisgaard (2000). Fowl cholera. Revue Scientifique et Technique de OIE 19(2):626-37 DOI:10.1016/B978-0-7020-2862-5.50015-5.
Fill out the form below to connect with Kemin's vaccine experts.
The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.
© Kemin Industries, Inc. and its group of companies all rights reserved. ® ™ Trademarks of Kemin Industries, Inc., USA
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.
You are viewing Sub-Saharan Africa